Robotic arms with silicon wafers for semiconductor manufacturing
Reading Time: 2 minutes
Xi’s Emphasis
 
*The 15th issue of Qiushi journal, published on August 1, will feature a key article by the chairman Xi Jinping on accelerating the building of a Healthy China, which stresses that achieving this goal by 2035 is a strategic decision, and the 15th Five-Year Plan period is critical for making decisive progress.
 
Financial
 
*China’s regulators are set to impose systematic rules on brokerages regarding trading system access. Under the new framework, brokerages will be prohibited from providing differentiated technical or business resources to select clients.
 
*China’s top financial regulators, the NFRA, PBOC, CSRC and MOF jointly issued guidelines on improving financial institution governance, including a stricter vetting process for shareholder entry.
 
*PBoC held its work conference for the second half of 2026. It will continue to implement a moderately accommodative monetary policy and timely devise and roll out practical and effective incremental policies.
 
Industrial Economy
 
*The State Council Executive Meeting approved four nuclear power projects including the Phase I project in Zhuanghe, Liaoning Province. According to The Paper, total investment in these new projects will exceed 170 billion yuan.
 
*The State Administration for Market Regulation launched price compliance guidance for the photovoltaic sector. Leading enterprises are required to set examples by standardizing pricing and competition practices.
 
*Following the US earnings season, Google, Amazon and Microsoft reported marked acceleration in their cloud business revenue. Meta drove revenue growth via AI-powered ad optimization. The combined backlog of cloud contracts at Amazon, Google and Microsoft nears $1.7 trillion, more than doubling year-on-year.
 
Jul 31 Block Trade Info
 
*Discount
 
-Jointown Pharmaceutical (600998 CH) saw 1 block trades worth 349.21mn at 5.10yuan per share, 0.97pct discount from last closing.
 
-Hengrui Pharmaceuticals (600276 CH) saw 2 block trades worth 313.78mn at 49.75yuan per share, 8.97pct discount from last closing.
 
-China Life Insurance (601628 CH) saw 1 block trades worth 174.47mn at 36.36yuan per share, 8.51pct discount from last closing.
 

For more insights, please visit Orient Futures Singapore’s research platform, 
Finoview.

Disclaimer

We, Orient Futures International (Singapore) Pte. Ltd. (“OFIS”) (UEN No. 201831776Z), hold a capital markets services licence (CMS100869) from the Monetary Authority of Singapore for dealing in capital market products such as futures/derivatives contracts, and spot foreign exchange contracts for the purposes of leveraged foreign exchange trading, and is an Exempt Financial Adviser. For more information about OFIS, please visit the MAS Financial Institutions Directory

All content, materials, information, data, statistics, features, research, documents or reports available on our website (including this article) which are financial in nature (the “Content”) are governed by our Terms of Use. By accessing, using or downloading any Content, you are deemed to have consented and agreed to the Terms of Use.

We distribute information/research (which may be prepared by us directly or produced by our foreign affiliated companies within the Orient Group of companies) pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. The information/research herein is prepared and distributed in Singapore and is intended for our clients who are Accredited Investors, Expert Investors or Institutional Investors only. If you are not an Accredited Investor, Expert Investor or Institutional Investor, you hereby acknowledge and agree that you are not the intended audience of all Content available on our website, and you undertake to immediately cease your access to any Content available on our website.

You agree to access and accept all Content available on our website on an “as-is” and “as available” basis. You agree that OFIS shall not have any responsibility or liability arising out of or in connection with, and you agree to waive the right to bring any claims or raise any complaints against OFIS in respect of any Content available on our website. OFIS shall also not be liable for any damage, loss or liability of any kind (whether actual, anticipated, consequential, special, economic or otherwise) caused as a result (direct or indirect) of the use of, or inability to access or use, the website, including but not limited to any damage, loss or liability suffered as a result of your reliance on the Content or our website.

OFIS does not make any representations, and hereby disclaim all warranties, express or implied, statutory or otherwise to the extent permitted by law, in respect of our website and all Content therein. To the fullest extent permissible, OFIS does not warrant and hereby disclaims any warranty as to the accuracy, correctness, completeness, reliability, timeliness, non-infringement, title, merchantability or fitness for any particular purpose of the Content.

All Content available on our website are general in nature and have been prepared without any consideration of your investment objectives, financial situations or needs. You should consider the appropriateness of any Content available on our website having regard to your personal circumstances before making any investment decisions. You should take into account your investment objectives and financial situation and seek advice from an independent financial advisor under a separate engagement if necessary.

Subscribe to our weekly newsletter to get the latest market news
Important: Protect yourself from fraudulent impersonation. Verify with us before engaging.Read more
+